Smith, 7, diagnosed with a rare blood disorder, receives a life-saving stem cell transplant from his father, Matt, offering ...

Data from the POLARGO trial potentially establishes a new standard of care for patients with R/R DLBCL ineligible for ...

Haematology's profound transformation offers new hope through advanced diagnostics, personalized medicine, and the noble act ...

Rates of grade III/IV acute GVHD at 3 months were 3% with cyclophosphamide-cyclosporin prophylaxis and 10% with standard ...